U.S. markets open in 7 hours 12 minutes

FUJIFILM Holdings Corporation (FUJIY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
71.05+0.21 (+0.30%)
At close: 3:45PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close70.84
Open70.32
Bid0.00 x 0
Ask0.00 x 0
Day's Range70.12 - 71.12
52 Week Range42.11 - 73.42
Volume7,664
Avg. Volume13,168
Market Cap28.404B
Beta (5Y Monthly)0.19
PE Ratio (TTM)17.42
EPS (TTM)4.08
Earnings DateN/A
Forward Dividend & Yield0.91 (1.26%)
Ex-Dividend DateSep 28, 2020
1y Target Est82.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Moody's

    Yestar Healthcare Holdings Company Limited -- Moody's downgrades Yestar's ratings to Caa1; outlook remains negative

    Rating Action: Moody's downgrades Yestar's ratings to Caa1; outlook remains negativeGlobal Credit Research - 14 Apr 2021Hong Kong, April 14, 2021 -- Moody's Investors Service has downgraded the corporate family rating (CFR) and senior unsecured rating of Yestar Healthcare Holdings Company Limited to Caa1 from B3.The outlook on the ratings remains negative.In its 2020 results announcement dated 7 April, Yestar indicated that there are significant uncertainties as to whether the company can continue as a going concern. For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.

  • Fujifilm CEO Komori, who oversaw push into healthcare, to step down in June
    Reuters

    Fujifilm CEO Komori, who oversaw push into healthcare, to step down in June

    Fujifilm Holdings Corp said on Wednesday that Shigetaka Komori, who oversaw the company's transition from film business to healthcare, would step down as chairman and chief executive in June. Komori, 81, will take a new role as chief adviser while Teiichi Goto becomes CEO and Kenji Sukeno the chairman. The transitions are subject to approval by shareholders, Fujifilm said in a release.

  • Is Fujifilm Holdings Corp. (FUJIY) Stock Undervalued Right Now?
    Zacks

    Is Fujifilm Holdings Corp. (FUJIY) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.